Korean J Pathol.  2000 May;34(5):341-348.

Expression of p27Kip1 Protein in Carcinoma of the Urinary Bladder

Affiliations
  • 1Department of Pathology and Medical Institute, Dongguk University College of Medicine, Kyungju 780-714, Korea.

Abstract

The cyclin-dependent kinase (cdk) inhibitor p27Kip1 gene is a powerful molecular determinant of cell cycle progression. Loss of expression of p27Kip1 has recently been shown to be predictive of disease progression in several human malignancies. The prognostic value and expression of p27Kip1 have been incompletely studied in bladder cancer. In this study, we investigated the relationship between p27Kip1 protein expression and clinicopathologic parameters in 50 cases of carcinoma of the urinary bladder by conducting immunohistochemical analysis and DNA flow-cytometry. Malignant bladder tissue demonstrated a heterogeneous pattern of p27Kip1 immunoreactivity. In addition, there was progressive loss of expression with increasing tumor grade. The expression of p27Kip1 protein was unrelated to stage, DNA ploidy and S phase fraction (SPF). SPF was unrelated with tumor grade and DNA ploidy. The results indicate that p27Kip1 is frequently expressed in well differentiated transitional cell carcinomas of the urinary bladder but less often expressed in muscle-invasive transitional cell carcinomas. The expression of p27Kip1 and its prevalence in low-grade tumors may reflect growth regulatory influences and potential inhibiting action in tumor progression and novel predictive markers of the biological potential of bladder tumors.

Keyword

Urinary bladder; Transitional cell carcinoma; p27Kip1

MeSH Terms

Carcinoma, Transitional Cell
Cell Cycle
Cyclin-Dependent Kinase Inhibitor p27*
Disease Progression
DNA
Humans
Phosphotransferases
Ploidies
Prevalence
S Phase
Urinary Bladder Neoplasms
Urinary Bladder*
Cyclin-Dependent Kinase Inhibitor p27
DNA
Phosphotransferases
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr